Hysingla and Fall - a phase IV clinical study of FDA data

Summary:

Fall is reported as a side effect among people who take Hysingla (hydrocodone bitartrate), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Hydrocodone Bitartrate And Acetaminophen, and have Pain.

The phase IV clinical study analyzes which people have Fall when taking Hysingla. It is created by eHealthMe based on reports of 32,589 people who have side effects when taking Hysingla from the FDA, and is updated regularly.

What is Hysingla?

Hysingla has active ingredients of hydrocodone bitartrate. eHealthMe is studying from 32,609 Hysingla users. Check the latest studies of Hysingla.

What is Fall?

Fall is found to be associated with 3,236 drugs and 3,759 conditions by eHealthMe. Check the latest studies of Fall.

On Jul, 20, 2026

32,589 people reported to have side effects when taking Hysingla.
Among them, 68 people (0.21%) have Fall.

Among these 68 people:

How long have people been on Hysingla when they have Fall? *

What is the gender of people who have Fall when taking Hysingla? *

female: 78.79 %
male: 21.21 %

What is the age of people who have Fall when taking Hysingla? *

What are other drugs people take besides Hysingla? *

Hydrocodone Bitartrate And Acetaminophen: 24 people, 35.29%
Oxycontin: 22 people, 32.35%
Dilaudid: 21 people, 30.88%
Palladone: 18 people, 26.47%
Ms Contin: 16 people, 23.53%
Butrans: 13 people, 19.12%
Dhc Plus: 12 people, 17.65%
Vitamin D3: 12 people, 17.65%
Norco: 12 people, 17.65%
Lyrica: 9 people, 13.24%

What are other side effects people have besides Fall? *

Drug Dependence: 30 people, 44.12%
Pain: 21 people, 30.88%
Overdose: 18 people, 26.47%
Head Injury: 17 people, 25.00%
Stress And Anxiety: 16 people, 23.53%
Pain In Extremity: 13 people, 19.12%
Fatigue (feeling of tiredness): 12 people, 17.65%
Headache (pain in head): 11 people, 16.18%
Balance Disorder: 10 people, 14.71%
Memory Loss: 10 people, 14.71%

What are the existing conditions these people have? *

Pain: 20 people, 29.41%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 6 people, 8.82%
Urethral Stricture Traumatic (narrowing of the urethra caused by-injury): 5 people, 7.35%
Cutaneous Lupus Erythematosus (own immune system attacks various cells causing a wide variety of signs and symptoms): 5 people, 7.35%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 7.35%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 4 people, 5.88%
Back Pain: 4 people, 5.88%
Neuropathy Peripheral (surface nerve damage): 4 people, 5.88%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 5.88%
Itching: 3 people, 4.41%

* Approximation only. Some reports may have incomplete information.

Do you take Hysingla and have Fall?

- Check whether Fall is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hysingla:

Hysingla (32,609 reports)

Fall treatments and more:

Fall (403,513 reports)

Browse all side effects of Hysingla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fall:

Fall (3,237 drugs)

Browse all the conditions that are associated with Fall:

Fall (3,759 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydrocodone bitartrate (the active ingredients of Hysingla) and Hysingla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.